Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set
Joanna Tieu(Queen Elizabeth Hospital), Catherine Hill(Royal Adelaide Hospital), Andrea Hinojosa‐Azaola(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Rachel Black(Royal Adelaide Hospital), Maarten de Witt(National Patient Safety Foundation), I. Z. Gaydukova(North-Western State Medical University named after I.I. Mechnikov), Robin Christensen(Frederiksberg Hospital), Karine Toupin‐April(Children's Hospital of Eastern Ontario), Peter Tugwell(University of Edinburgh), Lauren King(University of Toronto), Oscar Russell(Queen Elizabeth Hospital), Marco A Alba Garibay(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Susan M. Goodman(Hospital for Special Surgery), Corrado Campochiaro(Vita-Salute San Raffaele University), Joanna Robson(University of Bristol), Maarten Boers(Amsterdam UMC Location Vrije Universiteit Amsterdam), Kevin Yip(Hospital for Special Surgery), Suellen Anne Lyne(Flinders University), Chetan Mukhtyar(University of Oxford), Nilasha Ghosh(Hospital for Special Surgery), Michael George(University of Pennsylvania), Huai Leng Pisaniello(Basil Hetzel Institute), Beverley Shea(Community Living), Courage Uhunmwangho(University of Jos), Simon Décary(Université de Sherbrooke), Win Min Oo(The University of Sydney), Sebastian E. Sattui(Hospital for Special Surgery), Anthony P. Fernandez(Cleveland Clinic), Jasvinder A Singhi(University of Alabama at Birmingham), Helen Keen(The University of Western Australia), Michelle Petri(Johns Hopkins University), Lee S. Simon(Norfolk and Norwich University Hospital), C. Richard Hofstetter(National Patient Safety Foundation), Ashima Makol(Mayo Clinic), Margaret T. Whitstock(National Patient Safety Foundation), Jonathan TL. Cheah(UMass Memorial Health Care), Pamela Richards(National Patient Safety Foundation), Latika Gupta(Sanjay Gandhi Post Graduate Institute of Medical Sciences), Sarah Mackie, Vítor Teixeira(Algarve Biomedical Center)
Cited by 12
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
|Annals of the Rheumatic Diseases|2016|1.2k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k